Srilatha Edupuganti - Concepedia

Author

Srilatha Edupuganti

Also Known As

Burns, D., Cardozo-Ojeda, E. Fabian, Carlos del Rio, Colleen Kelley, Corey, Lawrence, Daniel Espinoza, Edupuganti, Srilatha, Francine Dyer, Frank S. Eder, Gama, Lucio

160

Publications

13.7K

Citations

H-Index

Concepts

All Affiliations

Emory University HOPE Clinic National Institute of Allergy and Infectious Diseases Fred Hutch Cancer Center University of Washington

About

Srilatha Edupuganti is an author at Emory University specializing in medicine, vaccination, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	23	6.2K
2	Allergy	4	4	902
3	Epidemiology	3	3	1.4K
4	Public Health	1	1	51
5	Cell Biology	1	1	516

Srilatha Edupuganti

Publications

12.5K

Citations

H-Index

Page 1

	Year	Citations
Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans Prabhu S. Arunachalam, Florian Wimmers, Chris Ka Pun Mok, Science Viral DiagnosticsImmunodeficienciesInnate Immune SystemImmunologyImmune Regulation	2020	1.3K
The receptor-binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients Lakshmanane Premkumar, Bruno Segovia-Chumbez, Ramesh Jadi, Science Immunology Clinical SymptomsViral DiagnosticsViral PathogenesisImmunologyImmunodominance	2020	968
Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection Jens Wrammert, Dimitrios Koutsonanos, Guimei Li, The Journal of Experimental Medicine VaccinationPandemic H1n1Vaccine DevelopmentNeutralizing AntibodiesVaccine Target	2011	797
Human Effector and Memory CD8+ T Cell Responses to Smallpox and Yellow Fever Vaccines Joseph D. Miller, Robbert van der Most, Rama Akondy, Immunity VaccinationHuman EffectorVaccine TargetImmunologyAutoimmunity	2008	607
Homologous and Heterologous Covid-19 Booster Vaccinations Robert L. Atmar, Kirsten E. Lyke, Meagan E. Deming, New England Journal of Medicine	2022	603
Human antibody responses after dengue virus infection are highly cross-reactive to Zika virus Lalita Priyamvada, Kendra M. Quicke, William Henry Hudson, Proceedings of the National Academy of Sciences	2016	583
Rapid Generation of Neutralizing Antibody Responses in COVID-19 Patients Mehul S. Suthar, Matthew G. Zimmerman, Robert C. Kauffman, Cell Reports Medicine	2020	541
Origin and differentiation of human memory CD8 T cells after vaccination Rama Akondy, Mark Fitch, Srilatha Edupuganti, Nature VaccinationImmunologyImmunodominanceAntigen ProcessingAutoimmunity	2017	516
Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition Lawrence Corey, Peter B. Gilbert, Michal Juraska, New England Journal of Medicine	2021	492
Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells Kristen W. Cohen, Susanne L. Linderman, Zoe Moodie, Cell Reports Medicine	2021	450

Page 1